Sunshine Biopharma launches generic prescription drug

Sunshine Biopharma (SBFM) announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched a new generic prescription drug. The newly launched drug is Ursodiol, a generic version of URSO DS. Ursodiol, also known as ursodeoxycholic acid, is indicated for the management of cholestatic liver diseases, including primary biliary cirrhosis. Ursodiol is also used to dissolve gallstones in people who do not want surgery or cannot have surgery to remove gallstones, or prevent the formation of gallstones in overweight people engaged in a rapid weight loss program. Nora Pharma’s Ursodiol is available for the Canadian market in 250 mg and 500 mg tablets.